Entinostat, also known as SNDX-275 and MS-275, is a benzamide histone deacetylase inhibitor undergoing clinical trials for treatment of various cancers.
{{chembox | Verifiedfields = changed | Watchedfields = changed | verifiedrevid = 444340516 | ImageFile = Entinostat.svg | ImageClass = skin-invert-image | ImageSize = 260 | PIN = (Pyridin-3-yl)methyl ({4-[(2-aminophenyl)carbamoyl]phenyl}methyl)carbamate | OtherNames = SNDX-275; MS-275 |Section1= |Section2= |Section3= | Section5 = }}
Entinostat, also known as SNDX-275 and MS-275, is a benzamide histone deacetylase inhibitor undergoing clinical trials for treatment of various cancers.
Discovered by embedding cosine similarity (sentence-transformers MiniLM, 384-dim).